Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...

Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The influenza virus vector-based nasal spray vaccine platform was first developed ...

They had given patients oral supplements of vitamin D to reduce nasal inflammation and reverse the loss of the sense of smell the inflammation often causes. "It helped zero of 28 people," she said.

“First line is usually some type of non-sedating antihistamine and or spray, nasal spray, like a Flonase," LoVecchio said. Despite the trees' allergy-inducing qualities in the spring, LoVecchio ...

“I was yesterday years old when I learned there was a wrong way to use [nasal spray] Flonase,” content creator Amber Guttilla declared in a recent viral TikTok. “I’ve been doing it wrong ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Centre for Virology, Vaccinology and Therapeutics (CVVT) have pioneered an influenza virus ...

One of the major categories of these treatments are antihistamines, which are available in pill, tablet, eye drop, or nasal spray forms ... These include fluticasone (Flonase), budesonide ...

She recommends over-the-counter nasal sprays and antihistamine eye drops as a starting point. Still, she says you should seek assistance from an allergist if you cannot find the right remedy or ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Riot police officers use pepper spray to clear a ...

Multiple swastikas were spray painted on the side of a building at the intersection of Fifth Street and Sharon Road. “This act of antisemitism is unacceptable and does not reflect the values of ...

Milestone® Pharmaceuticals (NASDAQ:MIST) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its New Drug Application (NDA) for CARDAMYST™ ...